Our findings revealed a significant correlation between elevated GPX3 expression and T stage, while no significant associations were observed with age, gender, lymph node metastasis, and clinical stage (Fig. 3B). The gene discussed is GPX3; the disease is metastatic malignant neoplasm in the lymph nodes.